Search

everythinglearnresearchcommunity

for

Search:↓

The S250C variant in a gene may cause autoimmunity and immunodeficiency by impairing protein function.

A specific gene mutation is linked to a hereditary form of dystonia that responds well to certain medications.

A new mutation in the ST14 gene causes a rare skin and hair disorder in a specific family.

Cancer treatment drugs can cause permanent hair loss by damaging hair follicle stem cells, but a specific inhibitor might reverse this effect.

Some prostate cancers have gene changes that may affect treatment with certain drugs.

Janus kinase inhibitors can help children with alopecia areata regrow hair but may have some risks.

H1 increases risk for neurodegenerative diseases, while H2 offers protection but is linked to other disorders.

Mutant MK6a transgenes in mice cause blistering, hair loss, and potential human alopecia.

Deleting TNFα gene reduces skin cancer risk in certain mice.

Tissue-specific variation in mutant load complicates genetic counseling and prenatal diagnosis.

The risk of skin tumors becoming malignant depends on the specific skin cell type affected.

Certain HLA class II alleles increase or decrease the risk of alopecia areata.

Irish dermatologists use JAK inhibitors for alopecia areata but want standardized treatment guidelines.

JAK inhibitors are safe and effective for treating moderate-to-severe alopecia areata.

Connexin mutations can cause various diseases like hearing loss and skin disorders.

Ruxolitinib can help regrow hair in severe alopecia areata.

Alopecia areata is caused by immune system issues, and JAK inhibitors might help treat it.

New mutations in the SLC39A4 gene found in twins help understand the genetic cause of acrodermatitis enteropathica.

Rapamycin may help treat Leigh syndrome by targeting protein kinase C.

Janus Kinase inhibitors are effective and safe for treating alopecia areata, but more research is needed.

Three molecular subtypes of advanced skin T-cell lymphoma were identified, with potential biomarkers for predicting treatment response and disease progression.

CYLD deficiency in skin tumors disrupts hair follicle cell processes and protein secretion.

The study developed a mouse model for Alopecia Areata that responds to treatment, useful for future research.

A new mutation in the LIPH gene was found to cause a rare hair disorder in a Japanese boy.

SQSTM1 is linked to increased risk of alopecia areata.

IGF2BP3 and other m6A-related genes are linked to keloid formation and could be potential treatment targets.

JAK inhibitors effectively treat severe alopecia areata with manageable side effects.

Janus kinase inhibitors show promise for treating alopecia areata but need more research for confirmation.